Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mannitol versus methacholine for airway hyperresponsiveness testing
NL-OMON21125Active, not recruiting
- Sponsor
- University Medical Center Groningen
- Start
- Jan 2007
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules, Inhalation Devices → Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
Randomised, single-blind trial of Bronchitol and methacholine in asthma and chronic obstructive pulmonary disease (COPD) (2 arms), sponsored by University Medical Center Groningen. Primary endpoint: Time involved in measurement of hyperresponsiveness. Started Jan 2007; status: active, not recruiting.
02
Drugs
Bronchitolmethacholine
03
Conditions
asthmachronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NL-OMON21125.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON21125.